Uroplasty (UPI) Inactive 10-Q2011 Q1 Quarterly report

Filed: 28 Jul 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: abroad, adding, administered, adversely, beginning, Canada, center, certificate, competing, deliver, direct, discontinuation, electrical, essentially, Europe, expansion, experienced, extent, FDA, global, grew, hypothetical, indefinitely, indirect, influenced, involved, key, launched, local, marketplace, mix, morbidity, opportunity, outpatient, pace, patient, payout, personnel, pharmaceutical, prefer, pulse, rapidly, reconsidered, requisite, sacral, side, significantly, size, stronger, surgery, transfer, treat, usage, varying, weaker

Removed: Additionally, agree, ASC, assurance, charge, clarify, create, decreased, encourage, ending, exercised, greater, impacted, Improving, largely, legal, location, obtain, policy, published, roll, September, Smaller, soft, spend, strategy, study, tissue, unique

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

UPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.1

Bonus Payout for Management

FY 2012 Plan


	Performance Band						Payout % of Compensation															Payout components % of Compensation
	% of Target						Total									Payout Ratio, percent						Sales									Operating Profit**									Business Milestones
	Min			Max			Min			Target			Max			Sales*		Operating Profit**		Business Milestone		Min			Target			Max			Min			Target			Max			Min			Target			Max

David Kaysen		90	%		110	%		30.00	%		60.00	%		80.00	%		60		20		20		18.00	%		36.00	%		48.00	%		6.00	%		12.00	%		16.00	%		6.00	%		12.00	%		16.00	%

Mahedi Jiwani		90	%		110	%		25.00	%		50.00	%		60.00	%		45		25		30		11.25	%		22.50	%		27.00	%		6.25	%		12.50	%		15.00	%		7.50	%		15.00	%		18.00	%

Susan Holman		90	%		110	%		20.00	%		30.00	%		50.00	%		45		25		30		9.00	%		13.50	%		22.50	%		5.00	%		7.50	%		12.50	%		6.00	%		9.00	%		15.00	%

Marc Herregraven		90	%		110	%		20.00	%		30.00	%		50.00	%		45		25		30		9.00	%		13.50	%		22.50	%		5.00	%		7.50	%		12.50	%		6.00	%		9.00	%		15.00	%

Larry Heinemann		90	%		110	%		20.00	%		30.00	%		50.00	%		60		20		20		12.00	%		18.00	%		30.00	%		4.00	%		6.00	%		10.00	%		4.00	%		6.00	%		10.00	%

Arie Koole		90	%		110	%		20.00	%		30.00	%		50.00	%		45		25		30		9.00	%		13.50	%		22.50	%		5.00	%		7.50	%		12.50	%		6.00	%		9.00	%		15.00	%

Nancy Kolb		90	%		110	%		20.00	%		30.00	%		50.00	%		45		25		30		9.00	%		13.50	%		22.50	%		5.00	%		7.50	%		12.50	%		6.00	%		9.00	%		15.00	%

* Actual Sales adjusted for fluctulations in exchange rates relative to the planned exchange rates

** Operating Profit to exclude non cash charges for depreciation, amortization and stock option grants

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.